Budget Impact Analysis of Impella CP(®) Utilization in the Management of Cardiogenic Shock in France: A Health Economic Analysis

INTRODUCTION: Early detection and treatment of cardiogenic shock (CS) is crucial to avoid irreparable multiorgan damage and mortality. Impella CP(®) is a novel temporary mechanical circulatory support (MCS) device associated with greater hemodynamic support and significantly fewer device-related com...

Descripción completa

Detalles Bibliográficos
Autores principales: Delmas, Clément, Pernot, Mathieu, Le Guyader, Alexandre, Joret, Romain, Roze, Stéphane, Lebreton, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918169/
https://www.ncbi.nlm.nih.gov/pubmed/35067868
http://dx.doi.org/10.1007/s12325-022-02040-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918169/
https://www.ncbi.nlm.nih.gov/pubmed/35067868
http://dx.doi.org/10.1007/s12325-022-02040-5

Ejemplares similares